Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 19 Jun 2026 for Coca-Cola HBC AG, €42k. Read the official filing
Filing timeline
BuySaleFrank O'Donnell
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Closed purchases
Market purchases
43
Positive at T+90
33%
Median T+90
-0.0%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
- -6.6%Entry £45.86 · Close 09 Oct 2026 £42.82
- -6.8%Entry £45.94 · Close 09 Oct 2026 £42.82
- +0.0%Entry £42.80 · Close 09 Oct 2026 £42.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frank O'Donnell: trading record in brief
Frank O'Donnell discloses dealings in Coca-Cola HBC AG to RNS (LSE). The record holds 51 filings, for trades running from 16 June 2023 to 17 June 2026.
Every open-market trade on record is a sale: 5 sales worth €4.4M. Outside the open market, there are 46 share grants. In 2026 alone, the filings show no purchases and 2 sales.
Ninety days after publication, 3 purchases show a median change of -0.0%, with the price up in 33% of them. These figures describe past trades and do not predict future prices.
The newest entry dates from 19 June 2026: a share grant of €42k, in Coca-Cola HBC AG. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (UK MAR). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Frank O'Donnell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
1,821.86 shares@ £19.8580.0003% mcap0.1% of flowXLONISIN CH0198251305RNS:9626124-9
Canonical exit: 15 Sept 2026 (T+90)
0XLONRNS:c429fc9a-8344-4620-bfca-ad06273394fc-9
Canonical exit: 15 Sept 2026 (T+90)
34,981.85 shares@ £781.5330.19% mcap99.8% of flowXLONISIN CH0198251305RNS:9619208-12
Canonical exit: 9 Sept 2026 (T+90)
0XLONRNS:9f0bc752-7a6b-44e3-99d8-0fff20d2763f-12
Canonical exit: 9 Sept 2026 (T+90)
1,759.24 shares@ £15.97480.1% of flowXLONISIN CH0198251305RNS:9576123-9
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:cfd77d8b-474a-4838-9d16-8d9b51a277e7-9
Canonical exit: 16 Aug 2026 (T+90)
0XLONRNS:e4673e71-fc27-4c38-a628-cfae4bc8b9f0-9
Canonical exit: 16 Jul 2026 (T+90)
21,461 shares@ £42.8160.0064% mcap17.1% of flowXLONISIN CH0198251305RNS:28e99025-53fc-41b3-a1c5-717a297ea0ba-9
15,099 shares@ £44.620.0047% mcap12.6% of flowOUTSIDE A TRADING VENUEISIN CH0198251305RNS:40364c27-a273-467d-9ce9-318f08b0bde1-10
0XLONRNS:b03dfd59-a0d2-4314-b28e-17fab2efb035-11
Canonical exit: 15 Jun 2026 (T+90)
16,434 shares@ £48.442414.7% of flowXLONISIN CH0198251305RNS:41290968-ec2c-4928-b4fa-6d65fb627267
0XLONRNS:c6180186-6052-45b4-a644-171ed0251413-11
Canonical exit: 18 May 2026 (T+90)
0XLONRNS:0b7e599b-e57b-4444-848c-34eae4c62517-12
Canonical exit: 16 Apr 2026 (T+90)
0XLONRNS:cf30e649-c5b6-41d8-9999-457b30522a78-12
Canonical exit: 17 Mar 2026 (T+90)
0XLONISIN CH0198251305RNS:5868283-12
Canonical exit: 15 Jan 2026 (T+90)
0XLONISIN CH0198251305RNS:5826797-12
Canonical exit: 16 Dec 2025 (T+90)
0XLONISIN CH0198251305RNS:5786734-12
Canonical exit: 16 Nov 2025 (T+90)
0XLONISIN CH0198251305RNS:5744521-13
Canonical exit: 15 Oct 2025 (T+90)
0XLONISIN CH0198251305RNS:5717857-13
Canonical exit: 25 Sept 2025 (T+90)
0XLONISIN CH0198251305RNS:5701895-13
Canonical exit: 15 Sept 2025 (T+90)
20,935 shares@ £38.898515.5% of flowXLONISIN CH0198251305RNS:5680039
0XLONISIN CH0198251305RNS:5662040-13
Canonical exit: 17 Aug 2025 (T+90)
0XLONISIN CH0198251305RNS:5624543-13
Canonical exit: 16 Jul 2025 (T+90)
21,694 shares@ £34.440714.4% of flowXLONISIN CH0198251305RNS:5595002-11
0XLONISIN CH0198251305RNS:5579070-13
Canonical exit: 15 Jun 2025 (T+90)
25 of 51 declarations
